课题基金 / 基金详情

Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues

Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues
剖析上皮屏障组织中炎症驱动的癌症易感性机制
批准号:
10305135
负责人:
Christopher Cowley
金额:
$4.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2023-08-31
关键词:
AcuteAddressAffectAwardBindingCancer BiologyCancer ModelCarcinomaCell physiologyCellsChromatinChronic DiseaseColitisColitis associated colorectal cancerColorectal CancerComplexCoupledDevelopmentDisease ProgressionDisease modelDisseminated Malignant NeoplasmEnhancersEpigenetic ProcessEpithelialEventExposure toFamilyGenesGenetic DiseasesGenetic ScreeningGenomicsGoalsHeadHomeostasisHumanInflammationInflammatoryInflammatory ResponseInstitutionLeadLifeLong-Term EffectsMAP Kinase GeneMaintenanceMalignant NeoplasmsMemoryModelingMolecularMolecular BiologyMusMutationNatural regenerationOncogenicOrganoidsPapillomaPathogenesisPathway interactionsPatientsPhasePhysiologicalPlayPostdoctoral FellowPredispositionRecurrenceRegenerative capacityResearchResolutionRiskRisk FactorsRoleSTAT3 geneSignal PathwaySkinSkin CarcinogenesisSpecialized Epithelial CellSquamous cell carcinomaStimulusStressStudentsSystemTechnical ExpertiseTechniquesTissuesTrainingTranscription Factor AP-1Transforming Growth Factor betaTumor BurdenTumor-DerivedWorkactivating transcription factor 3anticancer researchbiological adaptation to stresschromatin remodelingcytokineeffective therapyepigenetic memoryepigenomeepigenomicsepithelial stem cellexperiencehistone modificationhuman diseasein vivoinflammatory milieuinsightjun Oncogenemembermouse geneticsnovelnovel strategiesprematurepreventprofessorprogenitorrecruitregeneration potentialrestorationstemstem cell biologystem cell populationstem cellsstressortranscription factortranscriptomicstumortumor immunologytumorigenesiswound healing

项目摘要

项目成果

Christopher Cowley的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要: 长期以来,炎症一直被认为会增加肿瘤发生的风险。上皮屏障组织是 永远暴露在无数的环境和炎症性侮辱中,这需要强大的再生能力 其组织特异性上皮干细胞(EPSCs)恢复屏障完整性的能力。从长远来看 这些炎性接触对组织和EPSCs的影响尚不清楚。在这里,我试图 了解暴露在炎症中如何导致EPSCs及其谱系的表观遗传和细胞重新连接 在不同的屏障组织中,以及这种重新连接如何不适应导致癌症易感性增加。 本提案的F99阶段侧重于炎症体验的机制 皮肤上皮干细胞(EPSCs)染色质中的编码以及皮肤如何经历炎症 加速肿瘤的形成。我已经开始揭示EPSCs如何获得和 在与应激反应基因相关的关键区域保持染色质可及性,这些基因有助于 炎症反应。我的研究表明,这种现象是通过复杂和动态的 转录因子(TF)之间的相互作用,这些转录因子自然存在于稳定状态的EPSCs中,但无法获得 在没有炎症诱导的TF的情况下获得应激反应增强剂。当我发现分子机制的时候 ,我将询问这种皮肤EPSCs表观基因组的炎性重新连接如何加速肿瘤形成 随着EPSCs获得致癌突变导致鳞状细胞癌(SCCs),一种威胁生命的疾病, 转移性癌症,几乎没有有效的治疗方法。在F99阶段结束时,L将拥有 在体内高通量表观遗传学、小鼠遗传学和上皮干细胞生物学方面获得了丰富的经验, 并过渡到博士后,以获得人类癌症和免疫学方面的高级专业知识和培训。 对于K00阶段,我将把重点转移到炎症体验如何重塑结肠上皮 肠道中的成分,以及这种重塑以及EpSC表观遗传重排如何导致结直肠癌 (CRC)。有趣的是,结肠炎可以导致结肠炎诱导的结直肠癌,其遵循不同的分子驱动 其发病机制优于传统的结直肠癌。因此,为了进一步了解结肠炎诱导的CRC的机制, 我计划扩展我的技术专长,包括结肠炎诱导的CRC建模,单细胞表观基因组学和 转录组技术、基因筛选和人体器官模型。这些新方法结合在一起 以我在分子生物学和高通量基因组分析方面的深厚背景,将使我能够 解决当今炎症经验和癌症生物学中最紧迫和最具挑战性的问题。使用 在这个奖项的帮助下,我打算继续我的研究贡献,并获得必要的经验,成为 一个主要学术机构的助理教授。在那里,我将领导我自己的实验室,并引导我的学生 上皮癌研究的最终目标是找到新的靶点来治疗这些侵袭性癌症。
英文摘要
Project Summary/Abstract: Inflammation has long been known to increase risk of tumorigenesis. Epithelial barrier tissues are perpetually exposed to a myriad of environmental and inflammatory insults that necessitates robust regenerative capacity of their tissue-specific epithelial stem cells (EpSCs) to restore barrier integrity. The long term consequences of these inflammatory encounters on the tissue and EpSCs is poorly understood. Here, I seek to understand how exposure to inflammation results in epigenetic and cellular rewiring of EpSCs and their lineages in different barrier tissues and how this rewiring can be maladaptive leading to increased cancer susceptibility. The F99 phase of this proposal is focused on the mechanisms by which inflammatory experience is encoded within the chromatin of skin epithelial stem cells (EpSCs) and how inflammation-experienced skin accelerates tumor formation. I have begun to uncover the molecular mechanisms of how EpSCs acquire and maintain chromatin accessibility at key domains associated with stress response genes that contribute to an inflammatory response. My studies suggest that this phenomenon occurs through the complex and dynamic interplay between transcription factors (TFs) that are naturally present in steady state EpSCs but cannot gain access to stress response enhancers without inflammation-induced TFs. As I unearth the molecular mechanisms involved, I will interrogate how this inflammatory rewiring of skin EpSCs epigenome accelerates tumor formation as EpSCs acquire oncogenic mutations that lead to squamous cell carcinomas (SCCs), a life-threatening, metastatic cancer for which there are few effective therapies. At the completion of the F99 phase, l will have gained strong experience in in vivo high-throughput epigenetics, mouse genetics and epithelial stem cell biology, and transition to a postdoc to gain advanced expertise and training in human cancer and immunology. For the K00 phase, I will shift my focus to how inflammatory experience can reshape colonic epithelium composition in the gut and how this reshaping, along with EpSC epigenetic rewiring, results in colorectal cancer (CRC). Interestingly, colitis can result in colitis-induced CRC that follows a different molecular driven pathogenesis than traditional CRC. Thus, to further understand the mechanisms that drive colitis-induced CRC, I plan to expand my technical expertise to include colitis-induced CRC modeling, single-cell epigenomic and transcriptomic techniques, genetic screening and human organoid modeling. These new approaches coupled with my already strong background in molecular biology and high-throughput genomic analyses, will allow me to address the most pressing and challenging issues in inflammation experience and cancer biology today. With the aid of this award, I intend to continue my research contribution and gain the necessary experience to become an Assistant Professor at a major academic institution. There I will head my own lab and guide my students in epithelial cancer research with the ultimate goal of finding new targets to treat these aggressive cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues
  • 批准号:
    10818671
  • 项目类别:
  • 资助金额:
    $8.92万
  • 财政年份:
    2021
  • 负责人:
    Christopher Cowley
  • 依托单位:
海外基金